Lanzotyle DM Capsule contains Domperidone 15mg + Lansoprazole 10mg, a dual-action gastrointestinal formulation designed to control acid secretion while improving gastric motility. This combination effectively relieves symptoms such as heartburn, acid reflux, bloating, nausea, and vomiting associated with GERD and functional dyspepsia.
Lansoprazole, a proton pump inhibitor, reduces gastric acid production, while Domperidone enhances gastric emptying and prevents reflux by improving gastrointestinal motility. Together, they provide comprehensive and long-lasting symptom relief, improving patient comfort and digestive function.
For distributors, pharmacies, and hospital suppliers, Domedrag L Capsule is a high-rotation gastroenterology product, widely prescribed by gastroenterologists and general physicians. Chronic acid-related disorders ensure consistent demand and repeat market movement across OPD and IPD settings.
Including Lanzotyle DM Capsule in your portfolio strengthens your gastrointestinal and acid-control therapy segment, offering strong opportunities in hospital procurement, retail pharmacy distribution, export channels, and third-party manufacturing. Its broad therapeutic usage and high prescription rate make it a profitable and strategically important product for pharmaceutical distributors.